What if regenerative medicine could help the body recover function even after significant illness, injury, or degeneration—not simply help us prevent disease? This is the possibility that makes Photobiomodulation Plasma Therapy (PPT) so compelling. The technology is being explored in the context of some of medicine's most difficult challenges—including neurological injury and degeneration, cardiovascular dysfunction, metabolic disease, chronic pain, impaired vision, inflammatory conditions, and other complex states where repair has become limited. PPT combines your own platelet-rich plasma with precisely applied wavelengths of light designed to stimulate mitochondrial activity, ATP production, cellular signaling, and repair pathways. MD Biophysics is also investigating whether the technology may influence VSEL and other regenerative cell populations, potentially helping explain why a cellular approach could have relevance across very different tissues and organ systems.

​

The vision extends far beyond prevention or simply “optimizing wellness.” When the brain has been injured, the heart has lost capacity, metabolism has become dysfunctional, tissues remain painful, or degenerative processes have progressively limited someone's life, the question becomes: how much function might still be recoverable if we can improve the biological environment for repair? Rather than targeting one diagnosis at a time, PPT is designed to activate and amplify regenerative capacity already present within the body. That is what makes this emerging technology revolutionary to us: the possibility of helping people not only protect the health they have, but potentially recover function, expand capacity, and experience more life—even when biology has already been significantly challenged.

​

 

​